Published in:
01-08-2011 | Original Article
FCGR3A V(176) polymorphism for systemic lupus erythematosus susceptibility in Mexican population
Authors:
Aniel J. L. Brambila-Tapia, Jorge I. Gámez-Nava, Laura González-López, Lucila Sandoval-Ramírez, Julio Medína-Díaz, Montserrat Maldonado, Sergio R. Gutierrez-Ureña, Gloria Martínez-Bonilla, Beatriz T. Martín-Márquez, Mónica Vázquez del Mercado, Arnulfo Nava-Zavala, José F. Muñoz-Valle, Mario Salazar-Páramo, Ingrid P. Dávalos-Rodríguez
Published in:
Rheumatology International
|
Issue 8/2011
Login to get access
Abstract
The objective of this study is to establish whether there is an association between the presence of FCGR3A V(176) polymorphism with SLE or its manifestations. We included 94 patients according to the 1982 ACR criteria as well as 98 controls matched by age and gender. The 11 ACR diagnostic criteria were analyzed on the clinical files. The polymorphism FCGR3A V(176) was determined by direct sequencing. There was not an association between the polymorphism FCGR3A V(176) with SLE or its main manifestations. The allelic frequency for F(176) was: 0.80 and 0.72 in cases and controls, respectively (P = 0.09, IC95%: 0.42–1.07); and the genotypic frequency in the group of cases was: 0.65 for homozygotes F(176)/F(176), 0.30 for heterozygotes and 0.05 for the homozygotes V(176)/V(176), while for the control group it was 0.53, 0.39 and 0.08, respectively. The polymorphism FCGR3A V(176) is not associated with SLE or any of its manifestations in patients with SLE from the West of Mexico.